As shown in Figure 6 (the lower part), the HMGA2-driven gene signature in colorectal cancer patients was reversed by S100A4-knockdown (summary score = −96.55) and niclosamide (summary score = −81.98), but not by HMGA2-knockdown (summary score = −2.63). Here, S100A4 is linked to colorectal cancer.